Evergreen guides on purity, CoA reading, storage, and per-SKU laboratory overviews. Research use only.
Metabolic
Same backbone, same receptor, different fatty acid. That single structural decision drives the entire published-half-life difference between them. It is the cleanest example of how a small chemistry choice produces a large research-outcome change.
8 min read
Metabolic
Most "vs" searches arrive expecting a substitution decision. This one should not. Cagrilintide and Tirzepatide are co-administered in published research precisely because they engage different receptor families. The comparison frame is misleading; the combination frame is corr...
8 min read
Metabolic
They share the GLP-1 lineage and the lipidated structural pattern, which is exactly why labs misread the comparison. Tirzepatide engages two receptors, Semaglutide engages one, and downstream signalling diverges before any assay readout is even taken.
8 min read
Metabolic
Retatrutide adds a third receptor that Tirzepatide does not touch. That is the only sentence procurement needs to remember when one CoA review accidentally becomes the basis for the other.
8 min read
Metabolic
Long-acting GLP-1 receptor agonist analogue studied in vitro for incretin signaling, β-cell line response, and metabolic-pathway research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no ...
8 min read
Metabolic
Synthetic triagonist peptide studied in vitro at GLP-1, GIP, and glucagon receptors in metabolic-signaling research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read
Metabolic
Synthetic dual GLP-1 / GIP receptor agonist studied in vitro for combination incretin-pathway research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read
Metabolic
Acylated GLP-1 receptor agonist analogue studied in vitro for incretin-pathway and metabolic-signaling research. ≥99% HPLC. Research use only. This guide covers identity, published research context, procurement checks, and storage — RUO only, no clinical claims.
8 min read
Researcher verification
BluGen sells research-grade peptides exclusively to qualified researchers and laboratories for in-vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic or therapeutic procedures, and have not been evaluated by the U.S. Food and Drug Administration.